TW238309B - - Google Patents
Info
- Publication number
- TW238309B TW238309B TW081108218A TW81108218A TW238309B TW 238309 B TW238309 B TW 238309B TW 081108218 A TW081108218 A TW 081108218A TW 81108218 A TW81108218 A TW 81108218A TW 238309 B TW238309 B TW 238309B
- Authority
- TW
- Taiwan
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78225391A | 1991-10-24 | 1991-10-24 | |
| US79545691A | 1991-11-22 | 1991-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW238309B true TW238309B (OSRAM) | 1995-01-11 |
Family
ID=27119973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081108218A TW238309B (OSRAM) | 1991-10-24 | 1992-10-16 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH07500333A (OSRAM) |
| AU (1) | AU2559392A (OSRAM) |
| CA (1) | CA2118920A1 (OSRAM) |
| MX (1) | MX9205973A (OSRAM) |
| TW (1) | TW238309B (OSRAM) |
| WO (1) | WO1993008166A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5512566A (en) * | 1993-10-25 | 1996-04-30 | Ortho Pharmaceutical Corporation | Tricyclic compounds having affinity for the 5-HT1A receptor |
| EP0975595B9 (en) * | 1997-04-07 | 2009-09-16 | Georgetown University | Analogs of cocaine |
| TW200924752A (en) * | 2007-09-17 | 2009-06-16 | Organon Nv | Tricyclic heterocyclic derivatives |
| US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
| US8546377B2 (en) | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH630902A5 (en) * | 1977-01-24 | 1982-07-15 | Sandoz Ag | Process for preparing novel derivatives of 1,2,3,4,4a,10b-hexahydrobenzo(f)isoquinoline. |
| US4341786A (en) * | 1981-03-02 | 1982-07-27 | Smithkline Corporation | Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds |
| PT77267B (en) * | 1982-09-07 | 1986-03-21 | Lilly Co Eli | Improved process for preparing novel octahydrobenz <f> isoquinolines or compounds relating thereto |
| US5049564A (en) * | 1989-11-17 | 1991-09-17 | Abbott Laboratories | 5-HT selective agents |
| ES2090119T3 (es) * | 1988-12-15 | 1996-10-16 | Abbott Lab | Agentes selectivos de 5-ht. |
| GB8917333D0 (en) * | 1989-07-28 | 1989-09-13 | Merck Sharp & Dohme | Therapeutic agents |
| GB9014061D0 (en) * | 1990-06-25 | 1990-08-15 | Merck Sharp & Dohme | Therapeutic agents |
-
1992
- 1992-09-03 WO PCT/US1992/007314 patent/WO1993008166A1/en active Application Filing
- 1992-09-03 CA CA002118920A patent/CA2118920A1/en not_active Abandoned
- 1992-09-03 JP JP5507668A patent/JPH07500333A/ja active Pending
- 1992-09-03 AU AU25593/92A patent/AU2559392A/en not_active Abandoned
- 1992-10-16 TW TW081108218A patent/TW238309B/zh active
- 1992-10-16 MX MX9205973A patent/MX9205973A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2559392A (en) | 1993-05-21 |
| WO1993008166A1 (en) | 1993-04-29 |
| JPH07500333A (ja) | 1995-01-12 |
| CA2118920A1 (en) | 1993-04-29 |
| MX9205973A (es) | 1993-05-01 |